Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$31.47
-3.3%
$29.50
$21.97
$32.94
$1.39B1.62340,785 shs374,382 shs
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$32.77
+0.2%
$33.54
$27.07
$40.28
$1.33B1.31255,182 shs223,552 shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$44.89
-2.3%
$38.21
$26.56
$52.41
$1.33B0.8478,507 shs192,033 shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$9.52
-6.4%
$12.62
$5.45
$18.98
$333.56M1.93185,074 shs232,549 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
-3.32%+2.44%+8.49%+34.45%+21.04%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
+0.15%+1.71%-9.32%+6.63%-6.48%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-2.35%+2.28%+16.48%+47.96%+3.65%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-6.39%-6.89%-19.53%-8.64%+38.57%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Artivion, Inc. stock logo
AORT
Artivion
2.757 of 5 stars
1.65.00.00.02.72.51.9
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.6675 of 5 stars
2.31.02.50.01.13.31.9
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1.6164 of 5 stars
2.41.00.00.02.82.50.6
NeuroPace, Inc. stock logo
NPCE
NeuroPace
3.4872 of 5 stars
3.43.00.00.03.04.20.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artivion, Inc. stock logo
AORT
Artivion
3.17
Buy$32.402.96% Upside
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.50
Moderate Buy$37.5014.43% Upside
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.80
Moderate Buy$51.8015.39% Upside
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.83
Moderate Buy$15.5062.82% Upside

Current Analyst Ratings Breakdown

Latest NPCE, AORT, CDRE, and ESTA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/9/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$38.00 ➝ $47.00
6/17/2025
Artivion, Inc. stock logo
AORT
Artivion
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$35.00
6/13/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$45.00 ➝ $38.00
6/13/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$48.00
5/28/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$18.00
5/16/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Buy$62.00
5/14/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$48.00
5/14/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$14.00 ➝ $16.00
5/14/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$17.00 ➝ $17.00
5/6/2025
Artivion, Inc. stock logo
AORT
Artivion
Citizens Jmp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/6/2025
Artivion, Inc. stock logo
AORT
Artivion
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$33.00 ➝ $33.00
(Data available from 7/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artivion, Inc. stock logo
AORT
Artivion
$388.54M3.46$0.81 per share39.03$6.59 per share4.78
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$567.56M2.35$1.42 per share23.09$7.67 per share4.27
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$166.02M7.82N/AN/A$1.90 per share23.63
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$79.91M3.91N/AN/A$0.27 per share35.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artivion, Inc. stock logo
AORT
Artivion
-$13.36M-$0.50N/A62.94N/A-5.49%3.63%1.34%8/6/2025 (Estimated)
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$36.13M$0.9534.5024.101.216.87%12.52%6.04%8/8/2025 (Estimated)
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$84.60M-$3.10N/AN/AN/A-52.34%-196.25%-26.64%8/5/2025 (Estimated)
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$27.14M-$0.84N/AN/AN/A-29.42%-190.84%-25.08%8/12/2025 (Estimated)

Latest NPCE, AORT, CDRE, and ESTA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/8/2025Q2 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.25N/AN/AN/A$153.23 millionN/A
8/5/2025Q2 2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.54N/AN/AN/A$50.80 millionN/A
5/13/2025Q1 2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.26-$0.21+$0.05-$0.21$21.85 million$22.52 million
5/7/2025Q1 2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.83-$0.70+$0.13-$0.70$41.15 million$41.38 million
5/6/2025Q1 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.13$0.23+$0.10$0.23$121.53 million$130.11 million
5/5/2025Q1 2025
Artivion, Inc. stock logo
AORT
Artivion
$0.12$0.06-$0.06-$0.01$94.81 million$98.98 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Artivion, Inc. stock logo
AORT
Artivion
N/AN/AN/AN/AN/A
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.381.16%N/A40.00%2 Years
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A

Latest NPCE, AORT, CDRE, and ESTA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09501.29%5/2/20255/2/20255/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artivion, Inc. stock logo
AORT
Artivion
1.08
5.53
3.95
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.66
3.55
2.57
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
5.72
3.36
2.05
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.46
6.63
5.70

Institutional Ownership

CompanyInstitutional Ownership
Artivion, Inc. stock logo
AORT
Artivion
86.37%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%

Insider Ownership

CompanyInsider Ownership
Artivion, Inc. stock logo
AORT
Artivion
7.60%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
37.00%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11.09%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
20.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Artivion, Inc. stock logo
AORT
Artivion
1,60042.70 million39.46 millionOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,28440.66 million25.62 millionOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1,01828.92 million25.71 millionOptionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17032.80 million26.08 millionOptionable

Recent News About These Companies

NeuroPace Announces Strategic CFO Transition

New MarketBeat Followers Over Time

Media Sentiment Over Time

Artivion stock logo

Artivion NYSE:AORT

$31.47 -1.09 (-3.35%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$31.66 +0.19 (+0.59%)
As of 07/11/2025 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Cadre stock logo

Cadre NYSE:CDRE

$32.77 +0.06 (+0.18%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$32.76 -0.02 (-0.05%)
As of 07/11/2025 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$44.89 -1.08 (-2.35%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$46.02 +1.14 (+2.53%)
As of 07/11/2025 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

NeuroPace stock logo

NeuroPace NASDAQ:NPCE

$9.52 -0.65 (-6.39%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$9.62 +0.10 (+1.00%)
As of 07/11/2025 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.